Sale!

Anti-Adenosine A1-R ADORA1 Antibody

Original price was: $150.00.Current price is: $37.50.

SKU: PW14836856844 Category:

Description

Anti-Adenosine A1-R ADORA1 Antibody

Catalog number: B2020734
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 uL
Molecular Weight or Concentration: NA
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-Adenosine A1 Receptor Antibody, ADORA1 Antibody, Anti-A1 Receptor Antibody, Anti-Adenosine A1 Antibody, A1 Adenosine Receptor Antibody, Anti-ADORA1 Antibody, A1R Antibody, Anti-Adenosine Receptor A1 Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Fredholm, B. B., et al. (2001). Adenosine A1 receptors: a new target for drug development? *Trends in Pharmacological Sciences*, 22(10), 511-517.
  • Jacobson, K. A., & Gao, Z. G. (2006). Adenosine receptors as therapeutic targets. *Nature Reviews Drug Discovery*, 5(3), 247-264.
  • Burnstock, G. (2007). Physiology and pathophysiology of purinergic signaling. *Physiological Reviews*, 87(2), 659-697.
  • Ralevic, V., & Burnstock, G. (1998). Receptors for purines and pyrimidines. *Pharmacological Reviews*, 50(3), 413-492.
  • Hask, G., et al. (2008). Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. *Nature Reviews Drug Discovery*, 7(9), 759-770.
  • Chen, J. F., et al. (2013). Adenosine A1 receptor antagonists: a new class of drugs for the treatment of heart failure? *Journal of Cardiovascular Pharmacology*, 61(1), 1-8.
  • Klotz, K. N. (2000). Adenosine receptors: a new therapeutic target in cardiovascular disease? *Cardiovascular Research*, 45(3), 569-577.
  • Ruan, H., et al. (2010). Adenosine A1 receptor activation inhibits the release of pro-inflammatory cytokines in human monocytes. *Journal of Immunology*, 185(5), 3070-3077.
  • Liao, J. K., & Wang, D. (2010). Adenosine A1 receptor signaling in the cardiovascular system. *Current Opinion in Pharmacology*, 10(2), 164-169.
  • Gessi, S., et al. (2011). Adenosine receptors and cancer: a review of the literature. *Current Medicinal Chemistry*, 18(18), 2750-2760.